No­vo Nordisk to re­search oral obe­si­ty treat­ment; Dana-Far­ber taps in­to Har­bour Bio­Med's mice plat­form in mul­ti­year deal

No­vo Nordisk and Lu­men Bio­science have en­tered a re­search col­lab­o­ra­tion to ex­plore R&D and man­u­fac­tur­ing with­in obe­si­ty and oth­er meta­bol­ic dis­or­ders, the com­pa­nies

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER